{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T10:31:33Z","timestamp":1786444293870,"version":"build-2736575974"},"reference-count":96,"publisher":"Spandidos Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncol Lett"],"DOI":"10.3892\/ol.2026.15769","type":"journal-article","created":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T05:21:31Z","timestamp":1784265691000},"page":"1-10","source":"Crossref","is-referenced-by-count":0,"title":["Systems biology of Wnt signaling in glioma chemotherapy resistance: Integrating multi\u2011omics mechanisms and emerging therapeutic vulnerabilities (Review)"],"prefix":"10.3892","volume":"32","author":[{"given":"Qianru","family":"Zeng","sequence":"first","affiliation":[{"name":"Central Laboratory, Cancer Hospital of Shantou University Medical College, Shantou, Guangdong 515041, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuojun","family":"Chen","sequence":"additional","affiliation":[{"name":"Central Laboratory, Cancer Hospital of Shantou University Medical College, Shantou, Guangdong 515041, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rendong","family":"Zhang","sequence":"additional","affiliation":[{"name":"The Breast Center, Cancer Hospital of Shantou University Medical College, Shantou, Guangdong 515041, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongchao","family":"Pan","sequence":"additional","affiliation":[{"name":"Central Laboratory, Cancer Hospital of Shantou University Medical College, Shantou, Guangdong 515041, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2026,7,17]]},"reference":[{"key":"key20260811124546_b1-ol-32-3-15769","doi-asserted-by":"publisher","first-page":"iv1","DOI":"10.1093\/neuonc\/noaa200","article-title":"CBTRUS statistical report: Primary brain and other central nervous system tumors diagnosed in the United States in 2013\u20132017","volume":"22","author":"Ostrom","year":"2020","journal-title":"Neuro Oncol"},{"key":"key20260811124546_b2-ol-32-3-15769","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","article-title":"The 2021 WHO classification of tumors of the central nervous system: A summary","volume":"23","author":"Louis","year":"2021","journal-title":"Neuro Oncol"},{"key":"key20260811124546_b3-ol-32-3-15769","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1038\/ncpneuro0289","article-title":"Epidemiology and molecular pathology of glioma","volume":"2","author":"Schwartzbaum","year":"2006","journal-title":"Nat Clin Pract Neurol"},{"key":"key20260811124546_b4-ol-32-3-15769","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.gendis.2016.04.007","article-title":"Temozolomide resistance in glioblastoma multiforme","volume":"3","author":"Lee","year":"2016","journal-title":"Genes Dis"},{"key":"key20260811124546_b5-ol-32-3-15769","doi-asserted-by":"publisher","first-page":"e39984","DOI":"10.1016\/j.heliyon.2024.e39984","article-title":"Research progress of drug resistance mechanism of temozolomide in the treatment of glioblastoma","volume":"10","author":"Wu","year":"2024","journal-title":"Heliyon"},{"key":"key20260811124546_b6-ol-32-3-15769","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.mrrev.2017.10.001","article-title":"Epigenetic regulation of DNA repair genes and implications for tumor therapy","volume":"780","author":"Christmann","year":"2019","journal-title":"Mutat Res Rev Mutat Res"},{"key":"key20260811124546_b7-ol-32-3-15769","doi-asserted-by":"publisher","first-page":"3041","DOI":"10.1038\/s41388-020-1208-5","article-title":"EGFRvIII upregulates DNA mismatch repair resulting in increased temozolomide sensitivity of MGMT promoter methylated glioblastoma","volume":"39","author":"Struve","year":"2020","journal-title":"Oncogene"},{"key":"key20260811124546_b8-ol-32-3-15769","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/S0921-8777(01)00063-5","article-title":"The major human abasic endonuclease: Formation, consequences and repair of abasic lesions in DNA","volume":"485","author":"Wilson","year":"2001","journal-title":"Mutat Res"},{"key":"key20260811124546_b9-ol-32-3-15769","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s40478-025-02046-4","article-title":"Overcoming temozolomide resistance in glioma: Recent advances and mechanistic insights","volume":"13","author":"Li","year":"2025","journal-title":"Acta Neuropathol Commun"},{"key":"key20260811124546_b10-ol-32-3-15769","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1080\/15287394.2026.2618134","article-title":"Mechanisms associated with temozolomide resistance in U87MG cell line: In silico and in vitro approaches","volume":"89","author":"Conter","year":"2026","journal-title":"J Toxicol Environ Health A"},{"key":"key20260811124546_b11-ol-32-3-15769","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.3390\/biom13091408","article-title":"Multi-omics analyses reveal mitochondrial dysfunction contributing to temozolomide resistance in glioblastoma cells","volume":"13","author":"Zhang","year":"2023","journal-title":"Biomolecules"},{"key":"key20260811124546_b12-ol-32-3-15769","doi-asserted-by":"publisher","first-page":"4999","DOI":"10.7150\/ijbs.98396","article-title":"RUNX1-MUC13 interaction activates Wnt\/\u03b2-catenin signaling implications for colorectal cancer metastasis","volume":"20","author":"Chen","year":"2024","journal-title":"Int J Biol Sci"},{"key":"key20260811124546_b13-ol-32-3-15769","doi-asserted-by":"publisher","first-page":"567","DOI":"10.3390\/molecules26030567","article-title":"Effect of cetuximab-conjugated gold nanoparticles on the cytotoxicity and phenotypic evolution of colorectal cancer cells","volume":"26","author":"El Hallal","year":"2021","journal-title":"Molecules"},{"key":"key20260811124546_b14-ol-32-3-15769","doi-asserted-by":"publisher","first-page":"840241","DOI":"10.3389\/fonc.2022.840241","article-title":"Identification of synergistic drug combinations to target KRAS-driven chemoradioresistant cancers utilizing tumoroid models of colorectal adenocarcinoma and recurrent glioblastoma","volume":"12","author":"Gupta","year":"2022","journal-title":"Front Oncol"},{"key":"key20260811124546_b15-ol-32-3-15769","doi-asserted-by":"publisher","first-page":"3770","DOI":"10.1158\/1078-0432.CCR-22-0791","article-title":"FOXM1 variant contributes to gefitinib resistance via activating Wnt\/\u03b2-catenin signal pathway in patients with non-small cell lung cancer","volume":"28","author":"Guan","year":"2022","journal-title":"Clin Cancer Res"},{"key":"key20260811124546_b16-ol-32-3-15769","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1053\/j.gastro.2023.01.041","article-title":"N6-methyladenosine-mediated up-regulation of FZD10 regulates liver cancer stem cells' properties and lenvatinib resistance through WNT\/\u03b2-catenin and hippo signaling pathways","volume":"164","author":"Wang","year":"2023","journal-title":"Gastroenterology"},{"key":"key20260811124546_b17-ol-32-3-15769","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s12943-020-01237-y","article-title":"LncRNA PVT1 promotes gemcitabine resistance of pancreatic cancer via activating Wnt\/\u03b2-catenin and autophagy pathway through modulating the miR-619-5p\/Pygo2 and miR-619-5p\/ATG14 axes","volume":"19","author":"Zhou","year":"2020","journal-title":"Mol Cancer"},{"key":"key20260811124546_b18-ol-32-3-15769","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1016\/j.omtn.2020.01.030","article-title":"The lncRNA-GAS5\/miR-221-3p\/DKK2 axis modulates ABCB1-mediated Adriamycin resistance of breast cancer via the Wnt\/\u03b2-catenin signaling pathway","volume":"19","author":"Chen","year":"2020","journal-title":"Mol Ther Nucleic Acids"},{"key":"key20260811124546_b19-ol-32-3-15769","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3390\/jdb12030020","article-title":"Canonical and non-canonical Wnt signaling generates molecular and cellular asymmetries to establish embryonic axes","volume":"12","author":"Shi","year":"2024","journal-title":"J Dev Biol"},{"key":"key20260811124546_b20-ol-32-3-15769","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/s12943-025-02363-1","article-title":"Wnt\/\u03b2-catenin mediated signaling pathways in cancer: Recent advances, and applications in cancer therapy","volume":"24","author":"Wu","year":"2025","journal-title":"Mol Cancer"},{"key":"key20260811124546_b21-ol-32-3-15769","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1016\/j.cell.2012.05.012","article-title":"Wnt\/\u03b2-catenin signaling and disease","volume":"149","author":"Clevers","year":"2012","journal-title":"Cell"},{"key":"key20260811124546_b22-ol-32-3-15769","first-page":"507","article-title":"Modulating \u03b2-catenin homeostasis for cancer therapy","volume":"10","author":"Xu","year":"2024","journal-title":"Trends Cancer"},{"key":"key20260811124546_b23-ol-32-3-15769","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s12943-020-1133-9","article-title":"LncRNA JPX\/miR-33a-5p\/Twist1 axis regulates tumorigenesis and metastasis of lung cancer by activating Wnt\/\u03b2-catenin signaling","volume":"19","author":"Pan","year":"2020","journal-title":"Mol Cancer"},{"key":"key20260811124546_b24-ol-32-3-15769","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1038\/nature03319","article-title":"Wnt signalling in stem cells and cancer","volume":"434","author":"Reya","year":"2005","journal-title":"Nature"},{"key":"key20260811124546_b25-ol-32-3-15769","first-page":"1299","article-title":"MicroRNAs target the Wnt\/\u03b2-catenin signaling pathway to regulate epithelial-mesenchymal transition in cancer (review)","volume":"44","author":"Lei","year":"2020","journal-title":"Oncol Rep"},{"key":"key20260811124546_b26-ol-32-3-15769","doi-asserted-by":"publisher","first-page":"156111","DOI":"10.1016\/j.prp.2025.156111","article-title":"Molecular drivers of epithelial-mesenchymal transition (EMT) in glioblastoma and impact on therapy resistance","volume":"272","author":"Tian","year":"2025","journal-title":"Pathol Res Pract"},{"key":"key20260811124546_b27-ol-32-3-15769","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.semcdb.2021.11.020","article-title":"Local Wnt signalling in the asymmetric migrating vertebrate cells","volume":"125","author":"\u010cada","year":"2022","journal-title":"Semin Cell Dev Biol"},{"key":"key20260811124546_b28-ol-32-3-15769","first-page":"1583","article-title":"WNT\/PCP signaling pathway and human cancer (review)","volume":"14","author":"Katoh","year":"2005","journal-title":"Oncol Rep"},{"key":"key20260811124546_b29-ol-32-3-15769","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1158\/0008-5472.CAN-18-2757","article-title":"Wnt\/PCP signaling contribution to carcinoma collective cell migration and metastasis","volume":"79","author":"VanderVorst","year":"2019","journal-title":"Cancer Res"},{"key":"key20260811124546_b30-ol-32-3-15769","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/nrm.2017.11","article-title":"Planar cell polarity in development and disease","volume":"18","author":"Butler","year":"2017","journal-title":"Nat Rev Mol Cell Biol"},{"key":"key20260811124546_b31-ol-32-3-15769","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.ceca.2005.06.022","article-title":"Wnt and calcium signaling: \u03b2-catenin-independent pathways","volume":"38","author":"Kohn","year":"2005","journal-title":"Cell Calcium"},{"key":"key20260811124546_b32-ol-32-3-15769","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/bs.ctdb.2022.03.006","article-title":"Wnt-frizzled planar cell polarity signaling in the regulation of cell motility","volume":"150","author":"Koca","year":"2022","journal-title":"Curr Top Dev Biol"},{"key":"key20260811124546_b33-ol-32-3-15769","doi-asserted-by":"publisher","first-page":"26224","DOI":"10.1038\/s41598-024-77348-z","article-title":"High expression of LncRNA HOTAIR is a risk factor for temozolomide resistance in glioblastoma via activation of the miR-214\/\u03b2-catenin\/MGMT pathway","volume":"14","author":"Lan","year":"2024","journal-title":"Sci Rep"},{"key":"key20260811124546_b34-ol-32-3-15769","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1080\/10985549.2023.2210032","article-title":"CircTTLL13 promotes TMZ resistance in glioma via modulating OLR1-mediated activation of the Wnt\/\u03b2-catenin pathway","volume":"43","author":"Li","year":"2023","journal-title":"Mol Cell Biol"},{"key":"key20260811124546_b35-ol-32-3-15769","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1038\/s41419-021-04245-y","article-title":"A positive feedback loop of lncRNA-RMRP\/ZNRF3 axis and Wnt\/\u03b2-catenin signaling regulates the progression and temozolomide resistance in glioma","volume":"12","author":"Liu","year":"2021","journal-title":"Cell Death Dis"},{"key":"key20260811124546_b36-ol-32-3-15769","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1007\/s10571-020-00898-z","article-title":"LncRNA MIR155HG promotes temozolomide resistance by activating the Wnt\/\u03b2-catenin pathway via binding to PTBP1 in glioma","volume":"41","author":"He","year":"2021","journal-title":"Cell Mol Neurobiol"},{"key":"key20260811124546_b37-ol-32-3-15769","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.2147\/DDDT.S405450","article-title":"UBE2T promotes temozolomide resistance of glioblastoma through regulating the wnt\/\u03b2-catenin signaling pathway","volume":"17","author":"Wang","year":"2023","journal-title":"Drug Des Dev Ther"},{"key":"key20260811124546_b38-ol-32-3-15769","first-page":"157","article-title":"RNA sequencing identifies novel signaling pathways and potential drug target genes induced by FOSL1 in glioma progression and stemness","volume":"19","author":"Guo","year":"2025","journal-title":"Biologics"},{"key":"key20260811124546_b39-ol-32-3-15769","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1007\/s10495-021-01704-x","article-title":"WNT signaling modulates chemoresistance to temozolomide in p53-mutant glioblastoma multiforme","volume":"27","author":"Ma","year":"2022","journal-title":"Apoptosis"},{"key":"key20260811124546_b40-ol-32-3-15769","first-page":"1794","article-title":"Antitumor activity of cisplatin against malignant brain tumors","volume":"11","author":"Kato","year":"1984","journal-title":"Gan Kagaku Ryoho"},{"key":"key20260811124546_b41-ol-32-3-15769","doi-asserted-by":"publisher","first-page":"e2203958","DOI":"10.1002\/adma.202203958","article-title":"Brain co-delivery of temozolomide and cisplatin for combinatorial glioblastoma chemotherapy","volume":"34","author":"Zou","year":"2022","journal-title":"Adv Mater"},{"key":"key20260811124546_b42-ol-32-3-15769","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1111\/cns.13820","article-title":"Knockdown of circ_0055412 promotes cisplatin sensitivity of glioma cells through modulation of CAPG and Wnt\/\u03b2-catenin signaling pathway","volume":"28","author":"Zhou","year":"2022","journal-title":"CNS Neurosci Ther"},{"key":"key20260811124546_b43-ol-32-3-15769","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.ccell.2023.12.015","article-title":"Integrated proteogenomic characterization of glioblastoma evolution","volume":"42","author":"Kim","year":"2024","journal-title":"Cancer Cell"},{"key":"key20260811124546_b44-ol-32-3-15769","doi-asserted-by":"publisher","first-page":"562","DOI":"10.3390\/cells14080562","article-title":"Glioblastoma stem cells at the nexus of tumor heterogeneity, immune evasion, and therapeutic resistance","volume":"14","author":"Tang","year":"2025","journal-title":"Cells"},{"key":"key20260811124546_b45-ol-32-3-15769","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/s41388-022-02570-w","article-title":"EZH2 interacts with HP1BP3 to epigenetically activate WNT7B that promotes temozolomide resistance in glioblastoma","volume":"42","author":"Tang","year":"2023","journal-title":"Oncogene"},{"key":"key20260811124546_b46-ol-32-3-15769","doi-asserted-by":"publisher","first-page":"e70993","DOI":"10.1002\/cam4.70993","article-title":"Identification of the oncogenic role of MSH2 in the stemness and progression of glioma through regulating Wnt signaling pathway","volume":"14","author":"Liu","year":"2025","journal-title":"Cancer Med"},{"key":"key20260811124546_b47-ol-32-3-15769","doi-asserted-by":"publisher","first-page":"45654","DOI":"10.1038\/s41598-025-30291-z","article-title":"RGS20 reduces glioma stemness and temozolomide resistance by intrinsically inhibiting the WNT\/\u03b2-catenin signaling pathway","volume":"15","author":"Xie","year":"2025","journal-title":"Sci Rep"},{"key":"key20260811124546_b48-ol-32-3-15769","doi-asserted-by":"publisher","first-page":"101624","DOI":"10.1016\/j.gendis.2025.101624","article-title":"Targeting Wnt\/\u03b2-catenin activation in combination with temozolomide leads to glioblastoma inhibition and long-term survival in mice","volume":"13","author":"Zhang","year":"2026","journal-title":"Genes Dis"},{"key":"key20260811124546_b49-ol-32-3-15769","doi-asserted-by":"publisher","first-page":"22703","DOI":"10.18632\/oncotarget.25210","article-title":"Inhibition of wnt\/beta-catenin signaling downregulates expression of aldehyde dehydrogenase isoform 3A1 (ALDH3A1) to reduce resistance against temozolomide in glioblastoma in vitro","volume":"9","author":"Suwala","year":"2018","journal-title":"Oncotarget"},{"key":"key20260811124546_b50-ol-32-3-15769","first-page":"17","article-title":"Mechanisms of temozolomide resistance in glioblastoma-a comprehensive review","volume":"4","author":"Singh","year":"2021","journal-title":"Cancer Drug Resist"},{"key":"key20260811124546_b51-ol-32-3-15769","doi-asserted-by":"publisher","first-page":"eaay7522","DOI":"10.1126\/scitranslmed.aay7522","article-title":"Wnt-mediated endothelial transformation into mesenchymal stem cell-like cells induces chemoresistance in glioblastoma","volume":"12","author":"Huang","year":"2020","journal-title":"Sci Transl Med"},{"key":"key20260811124546_b52-ol-32-3-15769","doi-asserted-by":"publisher","first-page":"3165","DOI":"10.3390\/cancers14133165","article-title":"WNT\/\u03b2-catenin-mediated resistance to glucose deprivation in glioblastoma stem-like cells","volume":"14","author":"Yusuf","year":"2022","journal-title":"Cancers (Basel)"},{"key":"key20260811124546_b53-ol-32-3-15769","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.3390\/cells13181574","article-title":"Metabolic reprogramming in glioblastoma multiforme: A review of pathways and therapeutic targets","volume":"13","author":"Cortes Ballen","year":"2024","journal-title":"Cells"},{"key":"key20260811124546_b54-ol-32-3-15769","doi-asserted-by":"publisher","first-page":"206","DOI":"10.3390\/biology13040206","article-title":"Modular hub genes in DNA microarray suggest potential signaling pathway interconnectivity in various glioma grades","volume":"13","author":"Orda","year":"2024","journal-title":"Biology"},{"key":"key20260811124546_b55-ol-32-3-15769","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/s41374-021-00666-7","article-title":"Pharmacological inhibition of serine synthesis enhances temozolomide efficacy by decreasing O6-methylguanine DNA methyltransferase (MGMT) expression and reactive oxygen species (ROS)-mediated DNA damage in glioblastoma","volume":"102","author":"Jin","year":"2022","journal-title":"Lab Invest"},{"key":"key20260811124546_b56-ol-32-3-15769","doi-asserted-by":"publisher","first-page":"101113","DOI":"10.1016\/j.drup.2024.101113","article-title":"Increased oxygen stimulation promotes chemoresistance and phenotype shifting through PLCB1 in gliomas","volume":"76","author":"Ma","year":"2024","journal-title":"Drug Resist Updat"},{"key":"key20260811124546_b57-ol-32-3-15769","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.3390\/antiox14091121","article-title":"Oxidative stress and antioxidants in glioblastoma: Mechanisms of action, therapeutic effects and future directions","volume":"14","author":"Nowacka","year":"2025","journal-title":"Antioxidants"},{"key":"key20260811124546_b58-ol-32-3-15769","doi-asserted-by":"publisher","first-page":"1622218","DOI":"10.3389\/fcell.2025.1622218","article-title":"Targeting Wnt-driven metabolic adaptations in cancer: Integrating glycolysis, glutaminolysis, IDO1-mediated immune evasion, and therapeutic delivery strategies","volume":"13","author":"Flores-Hern\u00e1ndez","year":"2025","journal-title":"Front Cell Dev Biol"},{"key":"key20260811124546_b59-ol-32-3-15769","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s13045-020-00990-3","article-title":"Targeting the Wnt\/\u03b2-catenin signaling pathway in cancer","volume":"13","author":"Zhang","year":"2020","journal-title":"J Hematol Oncol"},{"key":"key20260811124546_b60-ol-32-3-15769","doi-asserted-by":"publisher","first-page":"110350","DOI":"10.1016\/j.cellsig.2022.110350","article-title":"Crosstalk between PI3K\/AKT\/mTOR and WNT\/\u03b2-catenin signaling in GBM-could combination therapy checkmate the collusion?","volume":"95","author":"Daisy Precilla","year":"2022","journal-title":"Cell Signal"},{"key":"key20260811124546_b61-ol-32-3-15769","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s10565-019-09502-7","article-title":"Temozolomide induces activation of Wnt\/\u03b2-catenin signaling in glioma cells via PI3K\/Akt pathway: Implications in glioma therapy","volume":"36","author":"Tomar","year":"2020","journal-title":"Cell Biol Toxicol"},{"key":"key20260811124546_b62-ol-32-3-15769","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1007\/s11060-026-05428-3","article-title":"Disrupting Akt-Wnt\/\u03b2-catenin signaling suppresses glioblastoma stem cell growth and tumor progression in immunocompetent mice","volume":"177","author":"Sarkar","year":"2026","journal-title":"J Neurooncol"},{"key":"key20260811124546_b63-ol-32-3-15769","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1111\/bph.17453","article-title":"SGK3 promotes estrogen receptor-positive breast cancer proliferation by activating STAT3\/ZMIZ2 pathway to stabilise \u03b2-catenin","volume":"182","author":"Yuan","year":"2025","journal-title":"Br J Pharmacol"},{"key":"key20260811124546_b64-ol-32-3-15769","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1007\/s10120-021-01186-5","article-title":"Crosstalk between WNT and STAT3 is mediated by galectin-3 in tumor progression","volume":"24","author":"Kim","year":"2021","journal-title":"Gastric Cancer"},{"key":"key20260811124546_b65-ol-32-3-15769","doi-asserted-by":"publisher","first-page":"e70340","DOI":"10.1111\/1756-185X.70340","article-title":"Modulation of Wnt\/\u03b2-catenin signaling by STAT3 inhibition restores myogenic capacity in sarcopenia","volume":"28","author":"Zhang","year":"2025","journal-title":"Int J Rheum Dis"},{"key":"key20260811124546_b66-ol-32-3-15769","doi-asserted-by":"publisher","first-page":"101096","DOI":"10.1016\/j.neo.2024.101096","article-title":"\u03b2-catenin mediated TAM phenotype promotes pancreatic cancer metastasis via the OSM\/STAT3\/LOXL2 axis","volume":"60","author":"Zhang","year":"2025","journal-title":"Neoplasia"},{"key":"key20260811124546_b67-ol-32-3-15769","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s12032-022-01897-4","article-title":"Ruxolitinib enhances cytotoxic and apoptotic effects of temozolomide on glioblastoma cells by regulating WNT signaling pathway-related genes","volume":"40","author":"Goker Bagca","year":"2022","journal-title":"Med Oncol"},{"key":"key20260811124546_b68-ol-32-3-15769","doi-asserted-by":"publisher","first-page":"2573","DOI":"10.3390\/cells9122573","article-title":"Revealing temozolomide resistance mechanisms via genome-wide CRISPR libraries","volume":"9","author":"Rocha","year":"2020","journal-title":"Cells"},{"key":"key20260811124546_b69-ol-32-3-15769","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.2147\/DDDT.S503167","article-title":"Platycodin D enhances glioma sensitivity to temozolomide by inhibition of the Wnt\/\u03b2-catenin pathway","volume":"19","author":"Li","year":"2025","journal-title":"Drug Des Dev Ther"},{"key":"key20260811124546_b70-ol-32-3-15769","doi-asserted-by":"publisher","first-page":"105348","DOI":"10.1016\/j.neuint.2022.105348","article-title":"Mannose inhibits proliferation and promotes apoptosis to enhance sensitivity of glioma cells to temozolomide through Wnt\/\u03b2-catenin signaling pathway","volume":"157","author":"Fei","year":"2022","journal-title":"Neurochem Int"},{"key":"key20260811124546_b71-ol-32-3-15769","doi-asserted-by":"publisher","first-page":"e70979","DOI":"10.1111\/jcmm.70979","article-title":"Modulation of Wnt\/\u03b2-catenin pathway by aesculus hippocastanum extract enhances temozolomide sensitivity in glioblastoma cells","volume":"30","author":"Scuderi","year":"2026","journal-title":"J Cell Mol Med"},{"key":"key20260811124546_b72-ol-32-3-15769","doi-asserted-by":"publisher","first-page":"116886","DOI":"10.1016\/j.bcp.2025.116886","article-title":"Natural small molecule thymoquinone increases the chemosensitivity of glioblastoma to temozolomide through inhibiting Wnt\/\u03b2-catenin signaling pathway to downregulate MGMT expression: In vitro and in vivo validation","volume":"236","author":"Bai","year":"2025","journal-title":"Biochem Pharmacol"},{"key":"key20260811124546_b73-ol-32-3-15769","doi-asserted-by":"publisher","first-page":"e0169854","DOI":"10.1371\/journal.pone.0169854","article-title":"Resveratrol impairs glioma stem cells proliferation and motility by modulating the Wnt signaling pathway","volume":"12","author":"Cilibrasi","year":"2017","journal-title":"PLoS One"},{"key":"key20260811124546_b74-ol-32-3-15769","doi-asserted-by":"publisher","first-page":"152058","DOI":"10.1016\/j.acthis.2023.152058","article-title":"Resveratrol as an antitumor agent for glioblastoma multiforme: Targeting resistance and promoting apoptotic cell deaths","volume":"125","author":"Karkon-Shayan","year":"2023","journal-title":"Acta Histochem"},{"key":"key20260811124546_b75-ol-32-3-15769","doi-asserted-by":"publisher","first-page":"3013","DOI":"10.1007\/s00262-022-03222-4","article-title":"High DKK3 expression related to immunosuppression was associated with poor prognosis in glioblastoma: Machine learning approach","volume":"71","author":"Han","year":"2022","journal-title":"Cancer Immunol Immunother"},{"key":"key20260811124546_b76-ol-32-3-15769","doi-asserted-by":"publisher","first-page":"e70359","DOI":"10.1002\/ctm2.70359","article-title":"Targeting the MDK\/c-Myc complex to overcome temozolomide resistance in glioma","volume":"15","author":"Xi","year":"2025","journal-title":"Clin Transl Med"},{"key":"key20260811124546_b77-ol-32-3-15769","doi-asserted-by":"publisher","first-page":"113738","DOI":"10.1016\/j.intimp.2024.113738","article-title":"Clofazimine enhances anti-glioma effect of immunotherapy","volume":"145","author":"Kosianova","year":"2025","journal-title":"Int Immunopharmacol"},{"key":"key20260811124546_b78-ol-32-3-15769","doi-asserted-by":"publisher","first-page":"5907","DOI":"10.3390\/ijms22115907","article-title":"NBM-BMX, an HDAC8 inhibitor, overcomes temozolomide resistance in glioblastoma multiforme by downregulating the \u03b2-catenin\/c-Myc\/SOX2 pathway and upregulating p53-mediated MGMT inhibition","volume":"22","author":"Tsai","year":"2021","journal-title":"Int J Mol Sci"},{"key":"key20260811124546_b79-ol-32-3-15769","doi-asserted-by":"publisher","first-page":"117411","DOI":"10.1016\/j.ejmech.2025.117411","article-title":"Discovery of a novel Wnt inhibitor DK419: Reversing temozolomide resistance in glioblastoma by switching off Wnt\/\u03b2-catenin signaling pathway to inhibit MGMT expression","volume":"288","author":"Bai","year":"2025","journal-title":"Eur J Med Chem"},{"key":"key20260811124546_b80-ol-32-3-15769","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1248\/cpb.c22-00815","article-title":"Modulating Wnt\/\u03b2-catenin signaling pathway on U251 and T98G glioblastoma cell lines using a combination of paclitaxel and temozolomide, a molecular docking simulations and gene expression study","volume":"71","author":"Jamalpour","year":"2023","journal-title":"Chem Pharm Bull (Tokyo)"},{"key":"key20260811124546_b81-ol-32-3-15769","doi-asserted-by":"publisher","first-page":"e2414941122","DOI":"10.1073\/pnas.2414941122","article-title":"Wnt inhibition alleviates resistance to anti-PD1 therapy and improves antitumor immunity in glioblastoma","volume":"122","author":"Krishnan","year":"2025","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20260811124546_b82-ol-32-3-15769","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s00262-025-03994-5","article-title":"Clofazimine enhances anti-PD-1 immunotherapy in glioblastoma by inhibiting Wnt6 signaling and modulating the tumor immune microenvironment","volume":"74","author":"Zhao","year":"2025","journal-title":"Cancer Immunol Immunother"},{"key":"key20260811124546_b83-ol-32-3-15769","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1093\/neuonc\/noac288","article-title":"Wnt signaling regulates MFSD2A-dependent drug delivery through endothelial transcytosis in glioma","volume":"25","author":"Xie","year":"2023","journal-title":"Neuro Oncol"},{"key":"key20260811124546_b84-ol-32-3-15769","doi-asserted-by":"publisher","first-page":"1363511","DOI":"10.3389\/fphar.2024.1363511","article-title":"Diethyldithiocarbamate-ferrous oxide nanoparticles inhibit human and mouse glioblastoma stemness: Aldehyde dehydrogenase 1A1 suppression and ferroptosis induction","volume":"15","author":"Abu-Serie","year":"2024","journal-title":"Front Pharmacol"},{"key":"key20260811124546_b85-ol-32-3-15769","doi-asserted-by":"publisher","first-page":"e70437","DOI":"10.1111\/cns.70437","article-title":"ANG-modified liposomes coloaded with \u03b1-melittin and resveratrol induce apoptosis and pyroptosis in glioblastoma cells by impeding Wnt\/\u03b2-catenin signaling","volume":"31","author":"Zhang","year":"2025","journal-title":"CNS Neurosci Ther"},{"key":"key20260811124546_b86-ol-32-3-15769","doi-asserted-by":"publisher","first-page":"115180","DOI":"10.1016\/j.colsurfb.2025.115180","article-title":"Tumor exosome-based drug delivery system targeting ferroptosis and apoptosis for glioblastoma therapy","volume":"257","author":"Xu","year":"2026","journal-title":"Colloids Surf B Biointerfaces"},{"key":"key20260811124546_b87-ol-32-3-15769","doi-asserted-by":"publisher","first-page":"121608","DOI":"10.1016\/j.biomaterials.2022.121608","article-title":"Targeted liposomes for combined delivery of artesunate and temozolomide to resistant glioblastoma","volume":"287","author":"Ismail","year":"2022","journal-title":"Biomaterials"},{"key":"key20260811124546_b88-ol-32-3-15769","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1007\/s13346-021-01017-1","article-title":"Tailoring drug co-delivery nanosystem for mitigating U-87 stem cells drug resistance","volume":"12","author":"Behrooz","year":"2022","journal-title":"Drug Deliv Transl Res"},{"key":"key20260811124546_b89-ol-32-3-15769","doi-asserted-by":"publisher","first-page":"897","DOI":"10.3390\/cells13110897","article-title":"Reprogramming glioblastoma cells into non-cancerous neuronal cells as a novel anti-cancer strategy","volume":"13","author":"Jiang","year":"2024","journal-title":"Cells"},{"key":"key20260811124546_b90-ol-32-3-15769","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1056\/NEJMoa043331","article-title":"MGMT gene silencing and benefit from temozolomide in glioblastoma","volume":"352","author":"Hegi","year":"2005","journal-title":"N Engl J Med"},{"key":"key20260811124546_b91-ol-32-3-15769","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/s41571-020-00447-z","article-title":"EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood","volume":"18","author":"Weller","year":"2021","journal-title":"Nat Rev Clin Oncol"},{"key":"key20260811124546_b92-ol-32-3-15769","doi-asserted-by":"publisher","first-page":"20250148","DOI":"10.1002\/VIW.20250148","article-title":"Application of 23Na MRI at 7 tesla in distinguishing IDH genotype, P53 phenotype, and ki-67 LI in adult-type diffuse gliomas","volume":"7","author":"Yuan","year":"2026","journal-title":"VIEW"},{"key":"key20260811124546_b93-ol-32-3-15769","doi-asserted-by":"publisher","first-page":"102238","DOI":"10.1016\/j.xcrm.2025.102238","article-title":"Metabolic fingerprinting enables rapid, label-free histopathology in gastric cancer diagnosis and prognostic prediction","volume":"6","author":"Teng","year":"2025","journal-title":"Cell Rep Med"},{"key":"key20260811124546_b94-ol-32-3-15769","doi-asserted-by":"publisher","first-page":"6108","DOI":"10.1038\/s41467-025-61163-9","article-title":"Serum metabolic profiling enables diagnosis, prognosis, and monitoring for brainstem gliomas","volume":"16","author":"Li","year":"2025","journal-title":"Nat Commun"},{"key":"key20260811124546_b95-ol-32-3-15769","doi-asserted-by":"publisher","first-page":"20240001","DOI":"10.1002\/VIW.20240001","article-title":"Multimodal data integration using deep learning predicts overall survival of patients with glioma","volume":"5","author":"Yuan","year":"2024","journal-title":"VIEW"},{"key":"key20260811124546_b96-ol-32-3-15769","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1038\/s41419-020-02988-8","article-title":"Wnt\/\u03b2-catenin signaling pathway induces autophagy-mediated temozolomide-resistance in human glioblastoma","volume":"11","author":"Yun","year":"2020","journal-title":"Cell Death Dis"}],"container-title":["Oncology Letters"],"original-title":[],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T09:45:52Z","timestamp":1786441552000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ol.2026.15769"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,17]]},"references-count":96,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,7,17]]}},"URL":"https:\/\/doi.org\/10.3892\/ol.2026.15769","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,17]]}}}